US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 30.100
  • -0.840-2.71%
Close May 2 16:00 ET
  • 30.100
  • 0.0000.00%
Post 16:20 ET
1.74BMarket Cap2.61P/E (TTM)

Agios Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.64%-111.49M
-31.68%-389.84M
-83.71%-133.17M
-36.62%-84.22M
-8.75%-72.59M
-4.92%-99.87M
4.34%-296.06M
-9.56%-72.49M
13.61%-61.64M
10.08%-66.75M
Net income from continuing operations
-9.49%-89.29M
291.35%673.73M
-0.61%-96.52M
1,137.97%947.92M
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
Operating gains losses
98.95%-2K
-38,234.48%-200.21M
-99.64%1K
-50,103.75%-200.02M
---1K
-27.33%-191K
1,193.75%525K
457.14%275K
2,005.26%400K
--0
Depreciation and amortization
-5.19%1.28M
-14.65%5.65M
-2.57%1.37M
-17.13%1.35M
-11.84%1.59M
-24.69%1.35M
-22.66%6.62M
-22.66%1.4M
-18.07%1.62M
-21.13%1.81M
Other non cash items
7.67%3.02M
-3,209.87%-877.61M
7.59%2.96M
-4,486.39%-886.23M
7.57%2.86M
7.48%2.8M
123.94%28.22M
102.20%2.75M
703.98%20.2M
6.93%2.66M
Change In working capital
-25.94%-36.51M
-3.73%-19.77M
-926.09%-46.26M
1,778.50%45.35M
164.98%10.13M
-12.45%-28.99M
-15.97%-19.06M
-50.52%5.6M
41.41%-2.7M
173.71%3.82M
-Change in receivables
218.97%765K
-115.07%-1.3M
39.35%-991K
-40.09%644K
34.67%-309K
-250.23%-643K
65.66%-604K
-199.82%-1.63M
183.33%1.08M
-129.51%-473K
-Change in inventory
50.20%-1.99M
19.31%-8.54M
34.13%-1.19M
-55.46%-2.49M
79.82%-867K
-38.58%-3.99M
-24.63%-10.58M
45.66%-1.8M
-43.64%-1.6M
-172.83%-4.3M
-Change in prepaid assets
48.08%-2.12M
-251.60%-5.81M
-127.94%-948K
-221.65%-5.35M
86.74%4.58M
-1,075.57%-4.09M
2,277.84%3.83M
-54.63%3.39M
59.43%-1.66M
1,585.45%2.45M
-Change in payables and accrued expense
-75.27%-29.11M
173.41%11.17M
-526.60%-39.01M
1,818.15%56.34M
7.86%10.45M
6.10%-16.61M
124.52%4.08M
5.62%9.15M
-26.35%2.94M
51.39%9.69M
-Change in other current liabilities
-10.93%-4.05M
3.18%-15.28M
-17.70%-4.12M
-9.80%-3.79M
-5.02%-3.73M
30.98%-3.65M
-101.74%-15.79M
-265.55%-3.5M
-64.58%-3.45M
-49.94%-3.55M
Cash from discontinued investing activities
Operating cash flow
-11.64%-111.49M
-31.68%-389.84M
-83.71%-133.17M
-36.62%-84.22M
-8.75%-72.59M
-4.92%-99.87M
4.34%-296.06M
-9.56%-72.49M
13.61%-61.64M
10.08%-66.75M
Investing cash flow
Cash flow from continuing investing activities
-9.61%112.59M
51.70%363.44M
-151.47%-49.16M
537.49%250.79M
-20.97%37.24M
116.27%124.56M
-1.52%239.58M
15.14%95.51M
-62.20%39.34M
-43.09%47.13M
Net PPE purchase and sale
-658.42%-766K
-604.60%-1.65M
-313.25%-967K
-151.99%-419K
-5,366.67%-158K
59.44%-101K
108.32%326K
-127.50%-234K
2,221.05%806K
100.16%3K
Net intangibles purchase and sale
----
--0
--0
----
----
----
---17.5M
--0
----
----
Net business purchase and sale
----
--1.09B
--0
----
----
----
--0
--0
----
----
Net investment purchase and sale
-9.07%113.35M
-382.01%-724.05M
-150.33%-48.19M
-1,595.36%-837.92M
-20.63%37.4M
115.51%124.66M
122.50%256.75M
292.71%95.75M
-46.18%56.04M
-44.39%47.12M
Cash from discontinued investing activities
Investing cash flow
-9.61%112.59M
51.70%363.44M
-151.47%-49.16M
537.49%250.79M
-20.97%37.24M
116.27%124.56M
-1.52%239.58M
15.14%95.51M
-62.20%39.34M
-43.09%47.13M
Financing cash flow
Cash flow from continuing financing activities
-72.39%1.62M
165.82%14.44M
471.66%4.84M
40.12%2.64M
363.71%1.1M
137.70%5.86M
131.19%5.43M
3,750.00%847K
58.55%1.88M
453.73%237K
Net issuance payments of debt
----
--0
----
----
----
----
--0
----
----
----
Proceeds from stock option exercised by employees
-72.39%1.62M
165.82%14.44M
471.66%4.84M
40.12%2.64M
363.71%1.1M
137.70%5.86M
102.65%5.43M
706.67%847K
48.07%1.88M
1,381.25%237K
Cash from discontinued financing activities
Financing cash flow
-72.39%1.62M
165.82%14.44M
471.66%4.84M
40.12%2.64M
363.71%1.1M
137.70%5.86M
131.19%5.43M
3,750.00%847K
58.55%1.88M
453.73%237K
Net cash flow
Beginning cash position
-13.56%76.25M
-36.66%88.21M
294.40%253.73M
-0.28%84.52M
14.04%118.76M
-36.66%88.21M
-31.44%139.26M
-47.46%64.33M
-4.28%84.75M
30.13%104.14M
Current changes in cash
-91.11%2.72M
76.58%-11.96M
-843.48%-177.48M
928.66%169.21M
-76.65%-34.25M
187.01%30.56M
20.06%-51.05M
42.01%23.87M
-160.23%-20.42M
-327.62%-19.39M
End cash Position
-33.51%78.96M
-13.56%76.25M
-13.56%76.25M
294.40%253.73M
-0.28%84.52M
14.04%118.76M
-36.66%88.21M
-36.66%88.21M
-47.46%64.33M
-4.28%84.75M
Free cash flow
-12.25%-112.26M
-24.47%-391.53M
-84.45%-134.13M
-6.45%-84.64M
-8.99%-72.75M
-4.63%-100.01M
-0.06%-314.56M
-9.73%-72.72M
-11.38%-79.51M
12.36%-66.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.64%-111.49M-31.68%-389.84M-83.71%-133.17M-36.62%-84.22M-8.75%-72.59M-4.92%-99.87M4.34%-296.06M-9.56%-72.49M13.61%-61.64M10.08%-66.75M
Net income from continuing operations -9.49%-89.29M291.35%673.73M-0.61%-96.52M1,137.97%947.92M-14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M
Operating gains losses 98.95%-2K-38,234.48%-200.21M-99.64%1K-50,103.75%-200.02M---1K-27.33%-191K1,193.75%525K457.14%275K2,005.26%400K--0
Depreciation and amortization -5.19%1.28M-14.65%5.65M-2.57%1.37M-17.13%1.35M-11.84%1.59M-24.69%1.35M-22.66%6.62M-22.66%1.4M-18.07%1.62M-21.13%1.81M
Other non cash items 7.67%3.02M-3,209.87%-877.61M7.59%2.96M-4,486.39%-886.23M7.57%2.86M7.48%2.8M123.94%28.22M102.20%2.75M703.98%20.2M6.93%2.66M
Change In working capital -25.94%-36.51M-3.73%-19.77M-926.09%-46.26M1,778.50%45.35M164.98%10.13M-12.45%-28.99M-15.97%-19.06M-50.52%5.6M41.41%-2.7M173.71%3.82M
-Change in receivables 218.97%765K-115.07%-1.3M39.35%-991K-40.09%644K34.67%-309K-250.23%-643K65.66%-604K-199.82%-1.63M183.33%1.08M-129.51%-473K
-Change in inventory 50.20%-1.99M19.31%-8.54M34.13%-1.19M-55.46%-2.49M79.82%-867K-38.58%-3.99M-24.63%-10.58M45.66%-1.8M-43.64%-1.6M-172.83%-4.3M
-Change in prepaid assets 48.08%-2.12M-251.60%-5.81M-127.94%-948K-221.65%-5.35M86.74%4.58M-1,075.57%-4.09M2,277.84%3.83M-54.63%3.39M59.43%-1.66M1,585.45%2.45M
-Change in payables and accrued expense -75.27%-29.11M173.41%11.17M-526.60%-39.01M1,818.15%56.34M7.86%10.45M6.10%-16.61M124.52%4.08M5.62%9.15M-26.35%2.94M51.39%9.69M
-Change in other current liabilities -10.93%-4.05M3.18%-15.28M-17.70%-4.12M-9.80%-3.79M-5.02%-3.73M30.98%-3.65M-101.74%-15.79M-265.55%-3.5M-64.58%-3.45M-49.94%-3.55M
Cash from discontinued investing activities
Operating cash flow -11.64%-111.49M-31.68%-389.84M-83.71%-133.17M-36.62%-84.22M-8.75%-72.59M-4.92%-99.87M4.34%-296.06M-9.56%-72.49M13.61%-61.64M10.08%-66.75M
Investing cash flow
Cash flow from continuing investing activities -9.61%112.59M51.70%363.44M-151.47%-49.16M537.49%250.79M-20.97%37.24M116.27%124.56M-1.52%239.58M15.14%95.51M-62.20%39.34M-43.09%47.13M
Net PPE purchase and sale -658.42%-766K-604.60%-1.65M-313.25%-967K-151.99%-419K-5,366.67%-158K59.44%-101K108.32%326K-127.50%-234K2,221.05%806K100.16%3K
Net intangibles purchase and sale ------0--0---------------17.5M--0--------
Net business purchase and sale ------1.09B--0--------------0--0--------
Net investment purchase and sale -9.07%113.35M-382.01%-724.05M-150.33%-48.19M-1,595.36%-837.92M-20.63%37.4M115.51%124.66M122.50%256.75M292.71%95.75M-46.18%56.04M-44.39%47.12M
Cash from discontinued investing activities
Investing cash flow -9.61%112.59M51.70%363.44M-151.47%-49.16M537.49%250.79M-20.97%37.24M116.27%124.56M-1.52%239.58M15.14%95.51M-62.20%39.34M-43.09%47.13M
Financing cash flow
Cash flow from continuing financing activities -72.39%1.62M165.82%14.44M471.66%4.84M40.12%2.64M363.71%1.1M137.70%5.86M131.19%5.43M3,750.00%847K58.55%1.88M453.73%237K
Net issuance payments of debt ------0------------------0------------
Proceeds from stock option exercised by employees -72.39%1.62M165.82%14.44M471.66%4.84M40.12%2.64M363.71%1.1M137.70%5.86M102.65%5.43M706.67%847K48.07%1.88M1,381.25%237K
Cash from discontinued financing activities
Financing cash flow -72.39%1.62M165.82%14.44M471.66%4.84M40.12%2.64M363.71%1.1M137.70%5.86M131.19%5.43M3,750.00%847K58.55%1.88M453.73%237K
Net cash flow
Beginning cash position -13.56%76.25M-36.66%88.21M294.40%253.73M-0.28%84.52M14.04%118.76M-36.66%88.21M-31.44%139.26M-47.46%64.33M-4.28%84.75M30.13%104.14M
Current changes in cash -91.11%2.72M76.58%-11.96M-843.48%-177.48M928.66%169.21M-76.65%-34.25M187.01%30.56M20.06%-51.05M42.01%23.87M-160.23%-20.42M-327.62%-19.39M
End cash Position -33.51%78.96M-13.56%76.25M-13.56%76.25M294.40%253.73M-0.28%84.52M14.04%118.76M-36.66%88.21M-36.66%88.21M-47.46%64.33M-4.28%84.75M
Free cash flow -12.25%-112.26M-24.47%-391.53M-84.45%-134.13M-6.45%-84.64M-8.99%-72.75M-4.63%-100.01M-0.06%-314.56M-9.73%-72.72M-11.38%-79.51M12.36%-66.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.